TrimRx's Blog

In its main obesity trial, CagriSema produced an average weight loss of about 22.7% over 68 weeks, which is among the highest seen for…

CagriSema’s side effects are mostly gastrointestinal, and while they’re common, the large majority are mild to moderate and fade over time. In the phase…

Petrelintide is an investigational weight-loss injection that works through amylin, a satiety hormone separate from the GLP-1 pathway, and its main selling point is…

VK2735 is an investigational obesity drug from Viking Therapeutics with a notable flexibility: it’s being developed in both an injectable form and an oral…

Mazdutide is a weekly weight-loss injection that’s notable for a milestone: it’s the world’s first approved drug to combine GLP-1 and glucagon activity in…

MariTide is an investigational weight-loss injection from Amgen with an unusual selling point: you’d take it just once a month, rather than once a…

Danuglipron was Pfizer’s attempt at an oral GLP-1 weight-loss pill, and the short answer to what happened is that Pfizer discontinued it in April…

Efpeglenatide is a once-weekly GLP-1 medication that stands out for one big reason: it’s backed by a major clinical trial showing it reduces the…

Losing a significant amount of weight changes more than your body, it changes the dynamics of your closest relationship, and talking openly with your…